Insider · CIK 0001447586
Todd A Becker
Files at GPRE (Green Plains Inc.), CORZ (Core Scientific, Inc./tx). First filing Mar 5, 2025, latest Mar 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CORZ: Core Scientific, Inc./tx
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | CORZsell Core Scientific, Inc./tx | $1.4M 134,250 shares | -41% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | GPRE Green Plains Inc. | FTax withholding Common Stock | -62,670 | $5.87 | $368k | 721,588 | Mar 11, 2025 |
| Mar 7, 2025 | GPRE Green Plains Inc. | AGrant or award Common Stock | +123,483 | $5.87 | $725k | 845,071 | Mar 11, 2025 |
| Mar 3, 2025 | CORZ Core Scientific, Inc./tx | SOpen-market sale Common Stock | -134,250 | $10.75 | $1.4M | 195,687 | Mar 5, 2025 |
| Mar 3, 2025 | CORZ Core Scientific, Inc./tx | SOpen-market sale Tranche 1 Warrantsderivative | -10,763 | $5.57 | $60k | 0 | Mar 5, 2025 |
| Mar 3, 2025 | CORZ Core Scientific, Inc./tx | SOpen-market sale Tranche 2 Warrantsderivative | -3,900 | $10.86 | $42k | 5,069 | Mar 5, 2025 |
| Mar 4, 2025 | CORZ Core Scientific, Inc./tx | SOpen-market sale Tranche 2 Warrantsderivative | -5,069 | $9.89 | $50k | 0 | Mar 5, 2025 |
| Jan 27, 2025 | CORZ Core Scientific, Inc./tx | AGrant or award Common Stock | +20,448 | $0.00 | $0 | 329,937 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.